According to FDA prescribing information, nausea occurs in approximately 15-30% of patients with type 2 diabetes and 24-46% of patients treated for obesity, with rates increasing at higher doses
Some patients report subjective improvements in energy levels and metabolic symptoms when using these medications, though such anecdotal reports cannot substitute for controlled clinical evidence
Call us today at 305-951-6648 Book Your Free Consultation FAQ Can you lose muscle while taking a GLP-1
FDX1 and LIAS, two key regulators of cuproptosis, are consistently upregulated in bulk RNA-seq, single-cell RNA sequencing, and spatial transcriptomics analyses in human samples (216)
I was putting on weight constantly and was feeling very hungry
During the transition window, some patients experience temporary hunger return or mild side effects as their system adjusts to the new medication